Held in collaboration with the Healthcare Infection Society
MDRGNBI have become prevalent across the globe. Their proliferation is fueled and encouraged by increased use of broad spectrum agents, and identification of successful treatment regimens have been challenged in recent years by the lack of new antibiotics available to treat them. Outbreaks of MDR infections adversely impact of patients quality of life, increase length of hospital stay and place considerable financial burdens on healthcare systems and services. Successfully rising to the combined challenges of infection prevention, improved diagnostics and appropriate treatment is essential if we are to be successful in reduction antibiotic resistance and improving patient outcomes.